🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients

Recruitingn/aAges 18 Years - 75 YearsAllChanghai Hospital
NCT07335705 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The primary objectives of this project are twofold. On the one hand, it aims to investigate the current status of bowel preparation protocols and their quality in IBD patients undergoing colonoscopy, particularly focusing on the implementation of these protocols across hospitals following the release of the 2023 bowel preparation guidelines. This will further standardize and optimize bowel preparation practices in China. On the other hand, the project seeks to identify and examine various risk factors contributing to poor bowel preparation quality in IBD patients, analyze their correlation with bowel preparation scores, and develop a risk prediction model for failed bowel preparation. This will provide a theoretical foundation for formulating personalized bowel preparation regimens tailored to individual patient conditions in the future.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients aged 18 years or older, of any gender, scheduled for colonoscopy; * Patients diagnosed with Inflammatory Bowel Disease (IBD) according to the 2023 edition of the Guidelines for the Diagnosis and Treatment of Inflammatory Bowel Disease; * Voluntary participation in this study and provision of signed informed consent. Exclusion Criteria: * History of acute myocardial infarction (within the past 6 months), severe cardiac, hepatic, or renal insufficiency, or psychiatric disorders; * Current use of anticoagulants (e.g., aspirin, warfarin) or presence of coagulation disorders; * Pregnant or lactating women; * Acute intestinal infection within the past 2 weeks; * History of colorectal tumors, familial adenomatous polyposis, or Peutz-Jeghers syndrome; * History of intestinal obstruction, perforation, stenosis, or any other condition preventing completion of the examination; * Severe hearing impairment, cognitive dysfunction, or inability to cooperate with the survey; * Individuals already enrolled in this study who schedule a repeat colonoscopy; * Currently participating in another clinical observational trial or having participated in any other clinical trial within the past 60 days; * Refusal to sign the written informed consent form.
💊

What it tests

  • Standard Pre-colonoscopy Bowel Preparation Protocol
📍

Where

1 site
Changhai Hospital
Shanghai, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy